As Valeant Pharmaceuticals prepares to defend its drug sales practices to Wall Street on Monday, new details are emerging about the tangled relationships – and litigation – among Valeant’s specialty pharmacy partners.
As Valeant Pharmaceuticals prepares to defend its drug sales practices to Wall Street on Monday, new details are emerging about the tangled relationships – and litigation – among Valeant’s specialty pharmacy partners.